Related Experiment Video
Updated: Aug 14, 2026

Minimally Invasive Endoscopic Intracerebral Hemorrhage Evacuation
Published on: October 15, 2021
Intracerebral hemorrhage
Neeraj Badjatia1, Jonathan Rosand
1Neurocritical Care and Acute Stroke Service, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. nbadjatia@neuro.columbia.edu
Insights
Intracerebral hemorrhage (ICH), a type of stroke, has high mortality. Management focuses on reducing hematoma expansion and secondary brain injury, with new treatments on the horizon.
Area of Science:
- Neurology
- Vascular Medicine
- Stroke Research
Background:
- Intracerebral hemorrhage (ICH) is a significant cause of stroke, accounting for 10% of cases in the US.
- ICH results from the rupture of small brain vessels, leading to high morbidity and mortality.
- Chronic hypertension and cerebral amyloid angiopathy are primary causes, with other factors including vascular malformations and anticoagulant use.
Purpose of the Study:
- To review the clinical course and management strategies for intracerebral hemorrhage.
- To highlight current understanding and remaining questions regarding ICH.
- To discuss acute and future therapeutic approaches for ICH.
Main Methods:
- Review of existing literature on intracerebral hemorrhage.
- Analysis of common risk factors and predisposing conditions.
- Discussion of current and emerging management principles.
Main Results:
- ICH management prioritizes reducing hematoma expansion in the acute phase.
- Controlling hemostasis, hemodynamics, and intracranial pressure is crucial for minimizing secondary brain injury.
- Despite advances, effective specific therapies for ICH are still under development, with agents like recombinant Factor VIIa showing promise.
Conclusions:
- Morbidity and mortality associated with ICH remain high.
- Further research into the mechanisms of ICH, including site predilection and hemorrhage timing, is needed.
- Novel preventive and acute treatment therapies are essential and may become available in the future.
Introduction:
Intracerebral hemorrhage (ICH) occurs from the rupture of small vessels into the brain parenchyma and accounts for approximately 10% of all strokes in the United States, and carries with it a significantly high morbidity and mortality.
Summary:
This article reviews the course and management of ICH. The most common chronic vascular diseases that lead to ICH are chronic hypertension and cerebral amyloid angiopathy. Additional factors that predispose to ICH include vascular malformations, chronic alcohol use, hypocholesterolemia, and use of anticoagulant medications. The understanding of mechanisms leading to ICH has advanced significantly, but questions regarding site predilection and timing of spontaneous hemorrhage still remain. Management in the acute setting is first focused on reducing hematoma expansion. Although no specific therapy has yet been proven effective, promising agents, particularly recombinant Factor VIIa, are on the horizon. Subsequent care is focused on controlling hemostasis, hemodynamics, and intracranial pressure in efforts to minimize secondary brain injury.
Conclusion:
The morbidity and mortality associated with ICH remain high despite recent advances in our understanding of the clinical course of ICH. Novel preventive and acute treatment therapies are needed and may be on the horizon.
Related Concept Videos
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Cerebral Edema ll: Pathophysiology
Increased Intracranial Pressure ll: Pathophysiology
Increased Intracranial Pressure l: Introduction
Cerebral Edema l: Introduction
